Table 3.
The Adverse events after treatment with CELcomplex® in the clinical study.
Adverse events | Grade 1 |
Grade 2 |
Total (average) | ||
---|---|---|---|---|---|
6 week (%) | 12 week (%) | 6 week (%) | 12 week (%) | ||
Headache | 4.5 | 4.5 | 2.4 | 2.4 | 3.5 |
Flatulence | 4.5 | 4.5 | 4.8 | 2.4 | 4.1 |
GIT-D | 4.5 | 0.0 | 2.4 | 4.8 | 2.9 |
no side effects | 86.5 | 91.0 | 90.0 | 90.0 | 89.4 |
Benefits | 100.0 | 100.0 | 88.0 | 100.0 | 97.0 |
Values are expressed as average, the benefits are epressed as percentuage (*p < 0.05), (**p < 0.01).